E-Poster presentation at MASCC Annual Meeting in Seattle, USA
2025-06-25
Report – The Case for BupiZenge™
2024-04-25
ARTICLES & NEWS
CEO interview with BioStock (ENG)
2025-10-13
CEO interview in Börs & Finans (SWE)
2024-06-18
CEO interview by Impala Nordic (SWE)
2024-01-03
Newsflash – Nordic Life Science
2025-01-28
EVENT PRESENTATIONS
Capital Markets Day (ENG)
2025-09-18
Life Science-dagen Göteborg / Finwire (SWE)
2025-03-05
Aktiespararna Digital Life Science event (SWE)
2024-08-28
Presentation at Carnegie – Bolagsdagen (SWE)
2024-03-11
Visit to development partner Galenica (SWE)
2024-02-27
VIDEO INTERVIEWS
Q4 Report Commentary w/ Impala Nordic (SWE)
2025-02-20
CEO interview at Redeye (SWE)
2024-11-28
Q2 report commentary at Redeye (SWE)
2024-08-27
Q4 report commentary at Carnegie (SWE)
2024-02-22
Chairman and CEO interview at Penser (SWE)
2023-11-13
PODCASTS
Podcast – Chris on the project, the future and life science
2024-05-13
Podcast – The backstory, with Niclas and Stian (SWE)
2024-02-21
RESEARCH & REPORTS
Redeye Research Note – OncoZenge Engages
LINK Medical
2025-06-04
Redeye Q1 Research Update – Pieces falling into place
2025-05-15
Redeye Research Note – Licensing Agreement
2025-04-11
Redeye Research Note – Binding Partnership Agreement
2025-03-28
Redeye Analysis – Q4 Research Update
2025-02-20
Report – The Case for BupiZenge ™
2024-04-25
Equity Analysis by Impala Nordic
2024-04-12
Equity analysis by Impala Nordic (SWE)
2024-01-16
Equity analysis by Impala Nordic (SWE)
2024-01-16
Equity analysis by Erik Penser Access (SWE)
2021-11-19